Paper Details 
Original Abstract of the Article :
Manifestations of malignant pleural effusions (MPEs) are alleviated by local therapies as well as by systemic treatment. After 2009, when commercial use of talc was discontinued in Korea, we have used Helixor-M, which is derived from the European mistletoe (Viscum album), as an alternative sclerosin...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1007/s00520-018-4455-z

データ提供:米国国立医学図書館(NLM)

Exploring Mistletoe as a Treatment for Lung Cancer

This research explores the potential of Viscum album extract (Helixor-M), derived from European mistletoe, as a sclerosing agent for treating malignant pleural effusion (MPE) in lung cancer patients. The study investigates the efficacy and safety of Helixor-M as an alternative to talc, which was discontinued in Korea after 2009. The researchers aimed to evaluate the effectiveness of Helixor-M in controlling MPE, a debilitating complication that often accompanies lung cancer.

A New Hope for Treating Malignant Pleural Effusion

The study's findings suggest that Helixor-M may offer a viable alternative to traditional sclerosing agents for treating MPE. The researchers evaluated the efficacy and safety of Helixor-M in a controlled setting, demonstrating its potential to alleviate the symptoms associated with MPE. This research offers a promising avenue for improving the quality of life for lung cancer patients experiencing this debilitating complication.

Navigating the Complexities of Lung Cancer Treatment

This research highlights the ongoing search for effective and safe treatment options for lung cancer, a formidable disease that often presents complex challenges. The investigation into Helixor-M's potential as a sclerosing agent demonstrates the commitment of researchers to finding new ways to address the specific needs of lung cancer patients. The exploration of alternative therapies, like Helixor-M, underscores the dynamic nature of medical research, constantly seeking better and more effective treatment strategies for the benefit of those affected by this disease.

Dr.Camel's Conclusion

This study offers a glimmer of hope in the fight against lung cancer, exploring the potential of a natural extract, Helixor-M, to combat the debilitating effects of malignant pleural effusion. Just as the desert provides surprising oases, this research reveals potential solutions within the natural world, offering new pathways for improving the lives of those battling this challenging disease. The journey towards effective lung cancer treatment is a continuous pursuit of innovation, and research like this sheds light on promising new avenues.

Date :
  1. Date Completed 2019-06-07
  2. Date Revised 2021-01-09
Further Info :

Pubmed ID

30218188

DOI: Digital Object Identifier

10.1007/s00520-018-4455-z

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.